RxSight, Inc. (RXST)
7.61
+0.23
(+3.12%)
USD |
NASDAQ |
Apr 17, 16:00
7.58
-0.03
(-0.39%)
Pre-Market: 08:28
RxSight SG&A Expense (Quarterly) : 27.70M for Dec. 31, 2025
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Alphatec Holdings, Inc. | 128.70M |
| Abbott Laboratories | 3.74B |
| Accuray, Inc. | 18.91M |
| Boston Scientific Corp. | 1.834B |
| Plus Therapeutics, Inc. | 4.168M |